Anadrolus 50 mg Driada Medical

Driada Medical ANADROLUS contains high-purity Oxymetholone standardized at 50 mg per tablet. Derived from dihydrotestosterone (DHT) with a modified 2-hydroxymethylene group, Oxymetholone is recognized as one of the most potent oral anabolic compounds in scientific research.

ANADROLUS is heavily studied in biochemical research models for its capacity to significantly increase red blood cell production via erythropoietin stimulation, enhance protein synthesis, and promote rapid nitrogen retention. Its 17-alpha-alkylated structure ensures high oral bioavailability, making it a foundational reference compound for studying severe tissue wasting recovery and acute anabolic response mechanisms.

Key Specifications

 Active Compound: Oxymetholone (Anadrol)

 Chemical Name: 17\beta\text{-hydroxy-2-hydroxymethylene-17}\alpha\text{-methyl-5}\alpha\text{-androstan-3-one}

 Molecular Formula: \text{C}_{21}\text{H}_{32}\text{O}_{3}

 Molecular Weight: 332.48\text{ g/mol}

 Concentration: 50 mg per tablet

 Formulation: Oral Tablets

 Manufacturer: Driada Medical

 Classification: 17$\alpha$-Alkylated Oral Anabolic Compound

Dosage & Research Protocol Guidelines

 Experimental Standard Dosage: In research and clinical evaluation models, standard reference protocols examine dosage ranges between 50 mg to 100 mg daily (1 to 2 tablets).

 Administration Frequency: Due to its active half-life of approximately 8 to 9 hours, daily administration is typically split into morning and evening doses to maintain steady plasma concentration.

 Research Duration: Protocol duration in animal and tissue models is typically restricted to 4 to 6 weeks due to 17$\alpha$-alkylated hepatic stress parameters.